HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Results of the first North American prescription heroin study are promising.

Abstract
In October 2008, the North American Opiate Medication Initiative (NAOMI) research team released the primary outcomes of a randomized controlled trial aimed at testing whether the provision of pharmaceutical-grade heroin under medical supervision benefits people suffering from chronic opiate addictions who have not benefitted from other treatments. The treatment phase was completed in June 2008. Retention and response rates were high, suggesting that heroin-assisted therapy is a safe and highly effective treatment for people with chronic heroin addiction.
AuthorsAlison Symington
JournalHIV/AIDS policy & law review (HIV AIDS Policy Law Rev) Vol. 13 Issue 2-3 Pg. 11-2 (Dec 2008) ISSN: 1712-624X [Print] Canada
PMID19294776 (Publication Type: Journal Article, Newspaper Article, Randomized Controlled Trial)
Chemical References
  • Heroin
Topics
  • Adult
  • Canada
  • Drug Prescriptions
  • Female
  • Heroin (administration & dosage)
  • Heroin Dependence (drug therapy)
  • Humans
  • Male
  • North America

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: